oxamniquine has been researched along with Urinary Tract Infections in 1 studies
Oxamniquine: An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
oxamniquine : A racemate comprising equimolar amounts of (R)- and (S)-oxamniquine. An anthelmintic, it is administered orally for the treatment of schistomiasis caused by Schistosoma mansoni (but not by other Schistosoma species); intramuscular administration is no longer used as it causes severe pain at the injection site.
{2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol : A member of the class of quinolines that is 1,2,3,4-tetrahydroquinoline which is substituted at positions 2, 6, and 7 by (isopropylamino)methyl, hydroxymethyl, and nitro groups, respectively.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Excerpt | Relevance | Reference |
---|---|---|
"Schistosomiasis is a major health problem in some areas of the world." | 1.31 | Impact of schistosomiasis on patient and graft outcome after renal transplantation: 10 years' follow-up. ( Baz, ME; El-Agroudy, AE; Ghoneim, MA; Mahmoud, KM; Mostafa, FE; Shokeir, AA; Sobh, MA, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahmoud, KM | 1 |
Sobh, MA | 1 |
El-Agroudy, AE | 1 |
Mostafa, FE | 1 |
Baz, ME | 1 |
Shokeir, AA | 1 |
Ghoneim, MA | 1 |
1 other study available for oxamniquine and Urinary Tract Infections
Article | Year |
---|---|
Impact of schistosomiasis on patient and graft outcome after renal transplantation: 10 years' follow-up.
Topics: Adult; Anthelmintics; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Transplanta | 2001 |